119 related articles for article (PubMed ID: 3140001)
1. Assessment of cytogenetic damage in chagasic children treated with benznidazole.
Gorla NB; Ledesma OS; Barbieri GP; Larripa IB
Mutat Res; 1988 Oct; 206(2):217-20. PubMed ID: 3140001
[TBL] [Abstract][Full Text] [Related]
2. Lack of sensitivity of sister-chromatid exchange for lymphocyte chromosomal damage detection caused by antichagasic treatment.
Gorla NB; Ledesma OS; Barbieri GP; Larripa IB
Toxicol Lett; 1991 Oct; 58(2):225-30. PubMed ID: 1949081
[TBL] [Abstract][Full Text] [Related]
3. Adverse events after the use of benznidazole in infants and children with Chagas disease.
Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the mutagenic potential of the antichagasic drug Rochagan in healthy and chagasic rodents.
Souza SC; Takahashi CS; da Silva JS
Mutat Res; 1991 Feb; 259(2):139-45. PubMed ID: 1899716
[TBL] [Abstract][Full Text] [Related]
5. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
Moya PR; Trombotto GT
Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
[No Abstract] [Full Text] [Related]
6. Should benznidazole be used in chronic Chagas' disease?
Bestetti RB
Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
[No Abstract] [Full Text] [Related]
7. Tolerance of benznidazole in treatment of Chagas' disease in adults.
Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J
Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286
[TBL] [Abstract][Full Text] [Related]
8. Low Incidence of Adverse Effects Using a Progressive Regimen of Benznidazole in Chagas Disease.
Navarrete MN; Gutiérrez-Gutiérrez B; de Arellano-Ramos R; Del Castillo SF; Domínguez-Castellano Á
Clin Infect Dis; 2016 Apr; 62(8):1052. PubMed ID: 26769725
[No Abstract] [Full Text] [Related]
9. Arthritis and benznidazole: more closely related than we thought.
Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J
Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100
[TBL] [Abstract][Full Text] [Related]
10. Tolerance of benznidazole in a United States Chagas Disease clinic.
Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
[TBL] [Abstract][Full Text] [Related]
11. Adverse systemic reaction to benznidazole.
Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH
Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820
[TBL] [Abstract][Full Text] [Related]
12. High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy.
Antinori S; Grande R; Bianco R; Traversi L; Cogliati C; Torzillo D; Repetto E; Corbellino M; Milazzo L; Galli M; Galimberti L
Clin Infect Dis; 2015 Jun; 60(12):1873-5. PubMed ID: 25805302
[No Abstract] [Full Text] [Related]
13. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil.
Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI
Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658
[TBL] [Abstract][Full Text] [Related]
14. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
[TBL] [Abstract][Full Text] [Related]
15. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
Carrilero B; Murcia L; Martínez-Lage L; Segovia M
Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
[TBL] [Abstract][Full Text] [Related]
16. [Thioctic acid in the prevention of the toxic effects of benznidazole].
Pérez Lloret A; Roldán EJ
Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012
[No Abstract] [Full Text] [Related]
17. Heart rate variability in chronic Chagas patients before and after treatment with benznidazole.
Oliveira LF; Silva VJ; Lages-Silva E; Molina RJ; Fuzissaki J; Niederhaur S; Prata A; Correia D
Auton Neurosci; 2010 Dec; 158(1-2):118-22. PubMed ID: 20558113
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Chagas disease with benznidazole and thioctic acid].
Roldán EJ
Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
[No Abstract] [Full Text] [Related]
19. [Peripheral polyneuropathy induced by benzonidazole in the treatment of Chagas' disease].
Defaria CR; De Melo-Souza SE; Rassi A
Arq Neuropsiquiatr; 1986 Jun; 44(2):125-9. PubMed ID: 3099734
[TBL] [Abstract][Full Text] [Related]
20. Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox.
Gorla NB; Ledesma OS; Barbieri GP; Larripa IB
Mutat Res; 1989 Oct; 224(2):263-7. PubMed ID: 2507913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
